Amling will assume the position long held by nationally renowned urologic surgeon John Barry, M.D. Barry has led the OHSU Division of Urology and Renal Transplantation for 29 years, earning a sterling reputation for his expertise in kidney transplantation, surgical diseases of the kidney, erectile dysfunction, Peyronie's disease and reconstructive urology. Barry now will focus on patient care and his work as president of the American Urological Association.
“I am excited about the future of OHSU urology and look forward to the opportunity to further build the reputation of the urology program that Dr. Barry dedicated himself to for so many years,” said John Hunter, M.D., Mackenzie Professor and Chairman of Surgery, OHSU School of Medicine.
“Dr. Amling changes the focus of the program from kidney transplantation to urologic cancer. He is a recognized national and international authority on cutting-edge treatments for prostate cancer, including robotic prostatectomy.”
Amling is an expert in advanced minimally invasive management of urologic diseases, including robotic surgery for prostate and bladder cancer, and prostate cancer and outcomes research. He is credited with developing innovative evaluation tools to enhance the education of surgical residents and has authored numerous scholarly articles that have improved methods for diagnosing and treating prostate cancer.
“Given Chris Amling’s expertise in prostate cancer, it will be natural for him to have an affiliation with the OHSU Knight Cancer Institute. His coming here will further establish our prostate cancer program as one of the best in the country,” said Brian Druker, M.D., director of the OHSU Knight Cancer Institute.
Amling previously served as professor and director of the Division of Urology at the University of Alabama at Birmingham, where he held the Anton J. Beuschen endowed chair in urologic surgery and research. Prior to that, he served as chairman of the Department of Urology at the Naval Medical Center in San Diego.
Amling is an Oregon native. He was born in Coquille and graduated from the University of Oregon and OHSU School of Medicine. He is a diplomate of the American Board of Urology; fellow in the American College of Surgeons; member of the American Urologic Association; president-elect of the Society of University Urologists; and a member of the editorial board of the Journal of Urology; reviewer for the Journal of the American Medical Association and the Journal of Urology and Cancer, as well as several other publications and honors.
Amling recently was selected as the 2009 recipient of the prestigious American Urological Association Gold Cystoscope award. This national award is given annually to one urologist in recognition of significant contributions to the specialty of urology within 13 years of completion of residency training.
About the OHSU Division of Urology
The OHSU Division of Urology is committed to excellence in the care of urology patients, clinical research, and training of urology fellows, residents and medical students. All disciplines of urology are represented by nationally and internationally recognized leaders in their field. The health care staff provides comprehensive services for adult and pediatric patients for a wide range of complex urologic problems. The faculty has special expertise in the treatment of all urologic diseases and disorders, including male infertility, incontinence and voiding dysfunction, stone disease, end stage renal disease, erectile dysfunction, pediatric urology and urologic oncology. The division provides laparoscopic and robotic surgery, endourology, renal transplantation, vasectomy reversal surgery, reconstructive urology, and surgical management of all urologic cancers.
About the OHSU Knight Cancer Institute
The OHSU Knight Cancer Institute is the only National Cancer Institute-designated center between Sacramento and Seattle. It comprises some 200 clinical researchers, basic scientists and population scientists who work together to translate scientific discoveries into longer and better lives for Oregon's cancer patients. In the lab, basic scientists examine cancer cells and normal cells to uncover molecular abnormalities that cause the disease. This basic science informs more than 300 clinical trials conducted at the OHSU Cancer Institute.
Oregon Health & Science University is the state’s only health and research university and Oregon’s only academic health center. OHSU is Portland's largest employer and the fourth largest in Oregon (excluding government), with 12,400 employees. OHSU's size contributes to its ability to provide many services and community support activities not found anywhere else in the state. It serves patients from every corner of the state, and is a conduit for learning for more than 3,400 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to every county in the state.